ScholarIQanswers from OpenAlex
Helsinn Therapeutics (United States)
InstitutionResearch output, impact & collaborations
Helsinn Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Helsinn Therapeutics (United States)?
ScholarIQrecord summary
Helsinn Therapeutics (United States) is a research organisation in Iselin, US. OpenAlex records 129 works and 13,871 citations for it. 30 researchers list it as their most recent affiliation.
How many works does Helsinn Therapeutics (United States) have?
ScholarIQindexed works
Helsinn Therapeutics (United States) has 129 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Helsinn Therapeutics (United States) have?
ScholarIQcitation count
Helsinn Therapeutics (United States) has 13,871 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Helsinn Therapeutics (United States)?
ScholarIQresearcher count
Helsinn Therapeutics (United States) has 30 researchers in the ScholarIQ index.
What is the average h-index at Helsinn Therapeutics (United States)?
ScholarIQavg h-index
Helsinn Therapeutics (United States) has an average h-index of 33 in OpenAlex.
What is the ROR of Helsinn Therapeutics (United States)?
ScholarIQror
The ROR for Helsinn Therapeutics (United States) is on the source record.
What is the OpenAlex record for Helsinn Therapeutics (United States)?
ScholarIQopenalex
The OpenAlex for Helsinn Therapeutics (United States) is on the source record.
Who are the most-cited researchers behind Helsinn Therapeutics (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Helsinn Therapeutics (United States)?
ScholarIQmost cited works
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review
J. Bradford Rice, Alan G. White, Lauren M. Scarpati, George J. Wan, Winnie W. Nelson
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Manesh R. Patel, Karen S. Pieper, Jonathan L. Halperin, Günter Breithardt, Daniel E. Singer, Graeme J. Hankey, Werner Hacke, Richard C. Becker, Scott D. Berkowitz, Christopher C. Nessel, Kenneth W. Mahaffey, Keith A.A. Fox, Robert M. Califf, J. Anderson, Noel W. Bedwell, Martin Bilsker, G. Keith Bruce, Ramtin Agah, M Desantis, Steven Eisenberg, A. Flores, Wolfgang Herzog, S Klein, H. Snyder, Steven K. Krueger, Erasmo de la Peña-Almaguer, EFI LAVIE, C. Lee, G. Mallis, Manish Modi, Graeme F. Woodworth, I. Niazi, Brenda Peart, Sri Sundaram, Brian Snoddy, Rodolfo Sotolongo, John B. Moloney, Kris Vijayaraghavan, F. Whittier, L. Yellen, Subhash Banerjee, Daniel L. Lustgarten, Dr.S Suresh, M. Gelernt, L Levinson, R. Ghanekar, G. Larsen Kneller, Christian Hall, Yazid Y. Fadl, Mark J. Pirwitz, William J. French, Nolan Mayer, Jian Bianca Pugeda, Kevin Steel, Freny Vaghaiwalla Mody, Amir Malik, H. Chandna, Alan S. Go, George Emlein, William W Bowden, Roberto Moscoso, Ruth Hodson, Michael Berk, Dengji Pan, Janine Pappas, Robert C. Orchard, G. Lynchard, Nampalli Vijay, Waqor Khan, Maher Khadra, Mark C Antonishen, Fred Cucher, Michael E. Staab, James S. Zebrack, S Borromeo, Jacqueline M. Heilman, Seemant Chaturvedi, Sravya Makam, Samir Turk, Thomas M. Hyers, George W. Williams, Ajay Labroo, SK Gill, Donald W. Myears, Jean Marc Weinstein, Jeffrey G. Shanes, Y. Chandrashekhar, Surbhi Shah, William M. Reiter, Tim Logemann, Adrian K. Almquist, Ravi Bhagwat, Tahir Tak, J. Shen‐Ling, Priyesh Patel, Andre Artis, Amy Arouni
Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
François Laliberté, Michel Cloutier, Winnie W. Nelson, Craig I Coleman, Dominic Pilon, William H. Olson, C.V. Damaraju, Jeffrey Schein, Patrick Lefèbvre
Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis
Alok A. Khorana, Keith R. McCrae, Dejan Milentijevic, Jonathan Fortier, Winnie W. Nelson, François Laliberté, Concetta Crivera, Patrick Lefèbvre, Daniel Yannicelli, Jeff Schein
Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
Alok A. Khorana, Daniel Yannicelli, Keith R. McCrae, Dejan Milentijevic, Concetta Crivera, Winnie W. Nelson, Jeffrey Schein
How much of the research on Helsinn Therapeutics (United States) is open access?
ScholarIQopen access share
45%OPEN ACCESS